A Comparison of the Outcomes in Fortiva and Strattice Mesh
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Oct 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of mesh used to repair ventral hernias, which are bulges in the abdominal wall. The study compares Fortiva mesh and Strattice mesh to see which one has better outcomes, specifically in terms of how often hernias come back after surgery and any complications related to the mesh.
If you are between the ages of 65 and 74 and have a ventral hernia that needs surgical repair, you might be eligible to participate in this trial. However, pregnant women cannot join. Participants will receive one of the two types of mesh during their surgery and will be monitored for recovery and any issues that may arise. This study is currently recruiting participants, and your involvement could help improve future hernia repair options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ventral Hernia requiring surgical repair
- Exclusion Criteria:
- • Pregnant women
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlotte, North Carolina, United States
Patients applied
Trial Officials
Todd Heniford, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials